Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients
On Demand
Share webinar
NGS has opened the door to powerful diagnostic and treatment opportunities in oncology — but, putting this technology into routine clinical practice isn’t always straightforward, and mainly because of technology availability, the sample quality and the analysis complexity.
That’s why the collaboration between OncoDNA and MGI is so relevant. Not only because this partnership enables more affordable access to NGS technology with all the benefits provided by the DNBSEQ technology, but also by providing better insights with the OncoDEEP/OncoKDM solutions from OncoDNA.
Koeraad EYCKEN, Chief product officer, OncoDNA
Filips Oleskovs, Business Development Manager, MGI
Alejandra María Pérez Sastre, PhD., Services Direction Manager, Sistemas Genómicos
